1. Abstract
The serial changes of serum complement proteins C4 and C3 in SLE were characterized in 33 pediatric SLE patients with defined C4 genotypes. Three distinct groups of C4 protein profiles were observed. The first group was characterized by persistently low C4 levels (<10 mg/dL) throughout the course of the study. Patients with this profile had mild disease manifestations and low to medium copy numbers of C4 genes. The second group featured periodic fluctuations of serum C4 protein concentrations above and below 10 mg/dL, paralleled with ups and downs of SLE disease activities. Most patients with the second profile had unequal copy numbers of C4A and C4B genes and relatively severe disease. The third group had normal serum C4 levels (>15 mg/dL) most of the time and occasionally low C4 and C3 levels that were mostly coincident with disease flares prior to effective medical treatment. Most patients in this group had medium to high C4 gene dosages. In SLE patients but not healthy subjects the serum C3 protein levels were tightly associated with serum C4 protein levels. It was found that a subject’s body mass index (BMI) is an important parameter in determining the serum C3 and C4 levels, both in SLE patients and healthy subjects. However, the BMI is unlikely to be involved in the parallel changes of C3 and C4 in SLE. As expected, the maximum serum C4 concentration present in a patient, which probably reflects the patient’s inherent capacity to produce a physiologic level of C4, was a function of her/his C4 gene dosage. Therefore, classifying C4 and C3 protein profiles and elucidating the genotypic and phenotypic variations of C4 may improve prediction of SLE disease flares and severity, and facilitate more effective management of the disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
7. References
J. A. Elliot and D. R. Mathieson, Complement in disseminated (systemic) lupus erythematosus, AMA Arch Dermatol Syphilol 68, 119–128 (1953).
E. J. Lewis, C. B. Carpenter, P. H. Schur, Serum complement component levels in human glomerulonephritis, Ann Intern Med 75, 555–560 (1971).
Y. Yang, E. K. Chung, B. Zhou, K. Lhotta, L. A. Hebert, D. J. Birmingham, B. H. Rovin, C. Y. Yu, The intricate role of complement C4 in human SLE, in Current Di rections in autoimmunity: complement in autoimmunity, Vol. 7, edited by G. C. Tsokos (Karger, Basel, 2004) pp. 98–132.
M.-L. Lokki, A. Circolo, P. Ahokas, K. L. Rupert, C. Y. Yu, H. R. Colten, Deficiency of complement protein C4 due to identical frameshift mutations in the C4A and C4B genes, J Immunol 162, 3687–3693 (1998).
Y. Yang, K. Lhotta, E. K. Chung, P. Eder, F. Neumair, C. Y. Yu, Complete complement components C4A and C4B deficiencies in human kidney diseases and systemic lupus erythematosus, J Immunol 173, 2803–2814 (2004).
K. L. Rupert, J. M. Moulds, Y. Yang, F. C. Arnett, R. W. Warren, J. D. Reveille, B. L. Myones, C. A. Blanchong, C. Y. Yu, The molecular basis of complete C4A and C4B deficiencies in a systemic lupus erythematosus (SLE) patient with homozygous C4A and C4B mutant genes, J Immunol 169, 1570–1578 (2002).
J. P. Atkinson, Complement deficiency. Predisposing factor to autoimmune syndromes, Am J Med 85, 45–47 (1988).
B. Z. Schmidt and H. R. Colten, Complement: a critical test of its biological importance, Immunol Rev 178, 166–176 (2000).
K. E. Sullivan, Complement deficiency and autoimmunity, Curr Opin Pediatr 10, 600–606 (1998).
A. H. L. Fielder, M. J. Walport, J. R. Batchelor, R. I. Rynes, C. M. Black, I. A. Dodi, G. R. V. Hughes, Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility, Br Med J 286, 425–428 (1983).
P. H. Schur, Complement testing in the diagnosis of immune and autoimmune diseases, Am J Clin Pathol 68, 647–659 (1978).
E. J. Lewis, Patterns of circulating complement in renal diseases, Annu Rev Med 30, 445–455 (1979).
J. M. Moulds, N. B. Warner, F. C. Arnett, Complement component C4A and C4B levels in systemic lupus erythematosus: quantitation in relation to C4 null status and disease activity, J Rheumatol 20, 443–447 (1993).
L. A. Hebert, F. G. Cosio, J. C. Neff, Diagnostic significance of hypocomplementemia, Kidney Int 39, 811–821 (1991).
Z. Yang, A. R. Mendoza, T. R. Welch, W. B. Zipf, C. Y. Yu, Modular variations of HLA class III genes for serine/threonine kinase RP, complement C4, steroid 21-hydroxylase CYP21 and tenascin TNX (RCCX): a mechanism for gene deletions and disease associations, J Biol Chem 274, 12147–12156 (1999).
C. A. Blanchong, B. Zhou, K. L. Rupert, E. K. Chung, K. N. Jones, J. F. Sotos, R. M. Rennebohm, C. Y. Yu, Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in Caucasians: the load of RCCX genetic diversity on MHC-associated disease, J Exp Med 191, 2183–2196 (2000).
C. Y. Yu, E. K. Chung, Y. Yang, C. A. Blanchong, N. Jacobsen, K. Saxena, Z. Yang, W. Miller, L. Varga, G. Fust, Dancing with complement C4 and the RP-C4-CYP21-TNX (RCCX) modules of the major histocompatibility complex, Prog Nucl Acid Res Mol Biol 75, 217–292 (2003).
C. Y. Yu and C. C. Whitacre, Sex, MHC and complement C4 in autoimmune diseases, Trends Immunol 25, 694–699 (2004).
E. K. Chung, Y. L. Wu, Y. Yang, B. Zhou, C. Y. Yu, Human complement components C4A and C4B genetic diversities: complex genotypes and phenotypes, in Cur rent protocols in immunology, edited by J. E. Coligan, B. E. Bierer, D. H. Margulis, E. M. Shevach and W. Strober (John Wiley & Sons, Inc. Edison, New Jersy, 2005), pp 13.8.1–13.8.36.
C. Y. Yu, C. A. Blanchong, E. K. Chung, K. L. Rupert, Y. Yang, Z. Yang, B. Zhou, and J. M. Moulds, in Manuals of clinical laboratory immunology, edited by N. R. Rose, R. G. Hamilton, B. Detrick (ASM Press, Washington, D.C., 2002), pp. 117–131.
E. Sim and S. Cross, Phenotyping of human complement component C4, a class III HLA antigen, Biochem J 239, 763–767 (1986).
G. Barba, C. Rittner, P. M. Schneider, Genetic basis of human complement C4A deficiency: detection of a point mutation leading to nonexpression, J Clin Invest 91, 1681–1686 (1993).
C. A. Johnson, P. Densen, R. K. Hurford, Jr., H. R. Colten, R. A. Wetsel, Type I human complement C2 deficiency. A 28-base pair gene deletion causes skipping of exon 6 during RNA splicing, J Biol Chem 267, 9347–9353 (1992).
E. M. Tan, A. S. Cohen, J. F. Fries, A. T. Masi, D. J. McShane, N. F. Rothfield, J. G. Schaller, N. Talal, R. J. Winchester, The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum 25, 1271–1277 (1982).
Y. Yang, E. K. Chung, B. Zhou, C. A. Blanchong, C. Y. Yu, G. Füst, M. Kovács, A. Vatay, C. Szalai, I. Karádi, L. Varga, Diversity in intrinsic strengths of the human complement system: serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities and body mass index, J Immunol 171, 2734–2745 (2003).
H. Gewurz, R. J. Pickering, S. E. Mergenhagen, R. A. Good, The complement profile in acute glomerulonephritis systemic erythematosus and hypocomplementemic chronic glomerulonephritis, Int Arch Allergy 34, 556–570 (1968).
P. F. Kohler and R. Ten Bensel, Serial complement component alterations in acute glomerulonephritis and systemic lupus erythematosus, Clin Exp Immunol 4, 191–202 (1969).
J. S. Cameron, M. H. Lessof, C. S. Ogg, B. D. Williams, D. G. Williams, Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations, Clin Exp Immunol 25, 418–427 (1976).
W. J. W. Morrow, D. A. Isenberg, A. Todd-Pokropek, H. F. Parry, M. L. Snaith, Useful laboratory measurements in the management of systemic lupus erythematosus, Q J Med 51(202), 125–138 (1982).
A. J. G. Swaak, J. Groenwold, W. Bronsveld, Predictive value of complement profiles and anti-DNA in systemic lupus erythematosus, Ann Rheum Dis 45, 359–366 (1986).
A. Ho, S. G. Barr, L. S. Magder, M. Petri, A decrease in complement is associated with increased renal and hemologic activity in patients with systemic lupus erythematosus, Arthritis Rheum 44, 2350–2357 (2001).
B. G. Gabrielsson, J. M. Johansson, M. Lonn, M. Jernas, T. Olbers, M. Peltonen, I. Larsson, L. Lonn, L. Sjostrom, B. Carlsson, L. M. Carlsson, High expression of complement components in omental adipose tissue in obese men, Obes Res 11, 699–708 (2003).
B. K. Averill and J. E. Bernal, Genetic and environmental influences on serum levels of human C4, Ann Hum Biol 11, 149–156 (1984).
A. Hammond, W. Ollier, M. J. Walport, Effects of C4 null alleles and homoduplications on quantitative expression of C4A and C4B, Clin Exp Immunol 88, 163–168 (1992).
E. Holme, S. J. Cross, J. Veitch, G. J. O’Neill, K. Whaley, Quantitation of human C4A and C4B, in serum and plasma by enzyme-linked immunoadsorbent assay, Immunogenetics 27, 295–297 (1988).
B. H. Rovin, Y. Tang, J. Sun, H. N. Nagaraja, K. V. Hackshaw, L. Gray, R. Rice, D. J. Birmingham, C. Y. Yu, D. N. Spetie, A. Aziz, L. A. Hebert, Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy, Kidney Int 68, 747–759 (2005).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, LLC
About this paper
Cite this paper
Wu, YL. et al. (2006). Three Distinct Profiles of Serum Complement C4 Proteins in Pediatric Systemic Lupus Erythematosus (SLE) Patients: Tight Associations of Complement C4 and C3 Protein Levels in SLE but not in Healthy Subjects. In: Lambris, J.D. (eds) Current Topics in Complement. Advances in Experimental Medicine and Biology, vol 586. Springer, Boston, MA. https://doi.org/10.1007/0-387-34134-X_16
Download citation
DOI: https://doi.org/10.1007/0-387-34134-X_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-32231-5
Online ISBN: 978-0-387-34134-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)